What is Vibhavadi Medical Center PCL EV-to-EBITDA?
Vibhavadi Medical Center PCLBKK:VIBHA-R 72 EV-to-EBITDA is 8.76 as of Jul. 03, 2026, which is 59% below its 10-year median of 21.51. GuruFocus rates BKK:VIBHA-R with a GF Score™ of 72/100 and a GF Value™ of ฿1.60. The stock has 5 warning signs investors should review. Among 507 Healthcare Providers & Services companies, Vibhavadi Medical Center PCL ranks better than 62.33% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Vibhavadi Medical Center PCL's enterprise value is ฿25,295 Mil.
Vibhavadi Medical Center PCL's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ฿2,888 Mil. Therefore, Vibhavadi Medical Center PCL's EV-to-EBITDA for today is 8.76.
The historical rank and industry rank for Vibhavadi Medical Center PCL's EV-to-EBITDA or its related term are showing as below:
BKK:VIBHA-R'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 8.66 Med: 21.51 Max: 34
Current: 8.76
During the past 13 years, the highest EV-to-EBITDA of Vibhavadi Medical Center PCL was 34.00. The lowest was 8.66. And the median was 21.51.
BKK:VIBHA-R's EV-to-EBITDA is ranked better than 62.33% of 507
companies
in the Healthcare Providers & Services industry
Industry Median: 10.92
vs BKK:VIBHA-R: 8.76
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Vibhavadi Medical Center PCL (BKK:VIBHA-R) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Vibhavadi Medical Center PCL's PE Ratio (TTM) for today is calculated as:
Vibhavadi Medical Center PCL's share price for today is ฿1.36.
Vibhavadi Medical Center PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.134.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:VIBHA-R vs HCA, THC, DVA: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Vibhavadi Medical Center PCL's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vibhavadi Medical Center PCL EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Vibhavadi Medical Center PCL's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Vibhavadi Medical Center PCL's EV-to-EBITDA falls into.
Vibhavadi Medical Center PCL's current Enterprise Value is ฿25,295 Mil.
Vibhavadi Medical Center PCL's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿2,888 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vibhavadi Medical Center PCL (BKK:VIBHA-R) has a EV-to-EBITDA of 8.76 as of Jul. 03, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Vibhavadi Medical Center PCL. This is 59% below median its historical median of 21.51. Over the past decade, Vibhavadi Medical Center PCL's EV-to-EBITDA has ranged from 8.66 to 34.00. According to the industry distribution chart, Vibhavadi Medical Center PCL ranks #191 out of 507 companies in the Healthcare Providers & Services industry, placing it in the top 37.7%.
Is Vibhavadi Medical Center PCL's EV-to-EBITDA too high?
Vibhavadi Medical Center PCL's current EV-to-EBITDA of 8.76 is 59% below median its 10-year median of 21.51. Over the past 10 years, this metric has ranged from a low of 8.66 to a high of 34.00. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.92. Vibhavadi Medical Center PCL's value of 8.76 is 19.8% below this industry median. Based on the distribution chart, Vibhavadi Medical Center PCL ranks #191 out of 507 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Vibhavadi Medical Center PCL has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Vibhavadi Medical Center PCL's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Vibhavadi Medical Center PCL ranks #191 out of 507 companies for EV-to-EBITDA. This puts Vibhavadi Medical Center PCL in the upper half of its industry. The industry median EV-to-EBITDA is 10.92. Vibhavadi Medical Center PCL's value of 8.76 is 19.8% below this benchmark. Historically, Vibhavadi Medical Center PCL's own EV-to-EBITDA has ranged from 8.66 to 34.00 over the past decade. While the company's 10-year median is 21.51 vs. the industry median of 10.92, Vibhavadi Medical Center PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.92, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vibhavadi Medical Center PCL's current EV-to-EBITDA of 8.76 is 19.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Vibhavadi Medical Center PCL. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vibhavadi Medical Center PCL's current EV-to-EBITDA is 8.76, which is 59% below median its own 10-year median of 21.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vibhavadi Medical Center PCL stock overvalued right now?
Vibhavadi Medical Center PCL (BKK:VIBHA-R) has a current EV-to-EBITDA of 8.76. The stock's GF Value™ is ฿1.60, compared to a current price of ฿1.36 — trading 15% below its estimated fair value. The current EV-to-EBITDA is 8.76, which is 59% below median its 10-year median of 21.51 and 19.8% below the Healthcare Providers & Services industry median of 10.92. Vibhavadi Medical Center PCL's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Vibhavadi Medical Center PCL (BKK:VIBHA-R), the current EV-to-EBITDA is 8.76 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vibhavadi Medical Center PCL (BKK:VIBHA-R) Overvalued in 2026?
Based on GuruFocus' analysis, Vibhavadi Medical Center PCL stock appears to be undervalued.
The current stock price of ฿1.36 is trading 15% below its estimated GF Value™ of ฿1.60.
Key valuation signals for BKK:VIBHA-R:
EV-to-EBITDA: 8.76 (59% below median its 10-year median of 21.51)
GF Value™: ฿1.60 vs. price of ฿1.36 (15% below fair value)
Industry Position: 19.8% below the Healthcare Providers & Services median (#191 of 507)
No single metric tells the full story. See the BKK:VIBHA-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vibhavadi Medical Center PCL provides the medical services known as Vibhavadi Hospital. The services provided include Pediatric Diseases, General Surgery, Orthopedic Center, General Medicine, Women's Health, Gastrointestinal Center, Cardiology, Neurology, Brain Tumor Surgery, Gamma Knife Radiosurgery for Brain, Cancer, Respiratory Diseases, Plastic Surgery, ENT (Ear, Nose, Throat) Department, Dental Center, Life Style Health Screening Center, Lasik Center, Eye, Hemodialysis Department, Dermatology Center, and Other Clinics and Services. Its segments include Hospital provides general hospital and hospital in social security; and Others provide rental services and rental space. The majority of the revenue is derived from the Hospital segment.
72GF Score
Get the complete analysis for BKK:VIBHA-R
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:VIBHA-R has been successfully added to your 
